5201 - 5225 of 7916 Results
Title
Year
-
OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: http://manuscript.elsevier.com/S135380201930032X/pdf/S135380201930032X.pdfCitation Count: 20
-
OPENTitle: Neural correlates of distinct cognitive phenotypes in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 399Issue #:Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013Best OA location URL: https://europepmc.org/articles/pmc6436969?pdf=renderCitation Count: 10
-
OPENTitle: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 879End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9Best OA location URL: https://europepmc.org/articles/pmc6533145?pdf=renderCitation Count: 94
-
OPENTitle: An estimate of the total number of true human miRNAsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 47Issue #: 7Start Page: 3353End Page: 3364Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkz097Best OA location URL: https://academic.oup.com/nar/article-pdf/47/7/3353/28467549/gkz097.pdfCitation Count: 443
-
RESTRICTEDTitle: A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 1Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181448Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181448?id=journal-of-parkinsons-disease%2Fjpd181448Citation Count: 11
-
OPENTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 130
-
OPENTitle: l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 30
- Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph2019OPENTitle: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorphJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0469-0Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0469-0Citation Count: 113
-
OPENTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: https://europepmc.org/articles/pmc6442034?pdf=renderCitation Count: 64
-
RESTRICTEDTitle: A review of basal ganglia circuits and physiology: Application to deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.009Best OA location URL: https://europepmc.org/articles/pmc7020857?pdf=renderCitation Count: 46
-
RESTRICTEDTitle: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 21End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016Citation Count: 16
-
OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://europepmc.org/articles/pmc6443492?pdf=renderCitation Count: 9
-
OPENTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 16
-
RESTRICTEDTitle: No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 74Issue #:Start Page: 236.e1End Page: 236.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.022Best OA location URL: http://manuscript.elsevier.com/S0197458018303476/pdf/S0197458018303476.pdfCitation Count: 1
-
OPENTitle: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0470-7Best OA location URL: https://doi.org/10.1186/s13195-019-0470-7Citation Count: 133
-
RESTRICTEDTitle: Physical activity mediates the association between striatal dopamine transporter availability and cognition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 68End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.027Citation Count: 31
-
OPENTitle: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian DisordersJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 3Start Page: 423End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669119Citation Count: 74
-
OPENTitle: Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.022Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/636639/2/1-s2.0-S1353802019300227-main.pdfCitation Count: 79
-
RESTRICTEDTitle: End of life planning in parkinsonian diseasesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.026Citation Count: 9
-
OPENTitle: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0073-1Best OA location URL: https://www.nature.com/articles/s41531-018-0073-1.pdfCitation Count: 28
-
OPENTitle: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 115Issue #:Start Page: 99End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016Best OA location URL: http://manuscript.elsevier.com/S0010945219300358/pdf/S0010945219300358.pdfCitation Count: 27
- Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions2019RESTRICTEDTitle: Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol InteractionsJournal Name: American Journal of EpidemiologyPublisher: Oxford University Press (OUP)Vol: 188Issue #: 6Start Page: 1033End Page: 1054Publication Date:Open Access(OA) Status: RESTRICTEDLicense: public-domain, public-domainDOI - Digital Object Identifier: 10.1093/aje/kwz005Best OA location URL: https://academic.oup.com/aje/article-pdf/188/6/1033/32921017/kwz005.pdfCitation Count: 92
- Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study2019OPENTitle: Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort StudyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-37545-zBest OA location URL: https://www.nature.com/articles/s41598-018-37545-z.pdfCitation Count: 120
-
OPENTitle: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved OutcomesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 3Start Page: 222End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12724Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12724Citation Count: 1
-
OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://manuscript.elsevier.com/S1353802019300215/pdf/S1353802019300215.pdfCitation Count: 40